Experimental Drug,Active Comparator No treatment

4 trials

Sponsors

Faculty of Medicine Ramathibodi Hospital, King Narai Hospital, Bhumibol Adulyadej Hospital

Conditions

How to prevent CMV infection in seropositive KT recipients receiving ATG induction therapy CMV, preemptive approach, valganciclovirIncremental hemodialysis Preserve residual kidney function (RKF) Residual kidney function (RKF) Incremental hemodialysis Spironolactone mineralocorticoid receptor antagonist 24-hour urine volume Residual urea clearance (Kru)Orofacial cysts requiring surgical management (enucleation/marsupialization) with postoperative neurosensory impairmen melatonin, neurosensory recovery, inferior alveolar nerve, orofacial cysts, oral surgerySecondary hyperparathyroidism End-stage renal disease Hypocalcemia after parathyroidectomy Calcitriol Parathyroidectomy Hypocalcemia Renal Dialysis Chronic Kidney Disease Phosphate Binders

Phase 3

Prophylaxis followed by Preemptive Approach versus Prophylaxis to Prevent CMV Infection in CMV-Seropositive Kidney Transplant Recipients Receiving Anti-thymocyte Globulin Induction Therapy

Active, not recruitingTCTR20240622001

Faculty of Medicine Ramathibodi HospitalHow to prevent CMV infection in seropositive KT recipients receiving ATG induction therapy CMV, preemptive approach, valganciclovir

Start: 2024-07-01Target: 50Updated: 2026-08-03

Patients Undergoing Parathyroidectomy: A Randomized Controlled Trial

RecruitingTCTR20251203001

King Narai HospitalSecondary hyperparathyroidism End-stage renal disease Hypocalcemia after parathyroidectomy Calcitriol Parathyroidectomy Hypocalcemia Renal Dialysis Chronic Kidney Disease Phosphate Binders

Start: 2021-07-01Target: 30Updated: 2026-08-03

Phase 4

Melatonin in Neurosensory Recovery after Orofacial Cyst Surgery

RecruitingTCTR20251127006

Orofacial cysts requiring surgical management (enucleation/marsupialization) with postoperative neurosensory impairmen melatonin, neurosensory recovery, inferior alveolar nerve, orofacial cysts, oral surgery

Start: 2025-04-07Target: 30Updated: 2026-08-03

Effects of Spironolactone on Residual Kidney Function in Incremental Hemodialysis Patients: A Randomized Controlled Trial

RecruitingTCTR20260227007

Bhumibol Adulyadej HospitalIncremental hemodialysis Preserve residual kidney function (RKF) Residual kidney function (RKF) Incremental hemodialysis Spironolactone mineralocorticoid receptor antagonist 24-hour urine volume Residual urea clearance (Kru)

Start: 2025-09-01Target: 34Updated: 2026-08-03